80
3
27
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10984 |
DDR-TRK-1
|
Discoidin Domain Receptor (DDR) | Tyrosine Kinase/Adaptors |
DDR-TRK-1 是 DDR1的一个选择性抑制剂,其 IC50 值为 9.4 nM。DDR-TRK-1 也抑制 TRK 激酶家族。 | |||
T31234 |
DDR-TRK-1N
DDR-TRK1N,DDRTRK-1N,DDRTRK1N,DDR-TRK 1N,DDR TRK-1N |
||
DDR-TRK-1N is a negative control for DDR-TRK-1. | |||
T34958 |
TRK-380
TAC301,TAC 301,TAC-301,TRK 380,TRK380 |
||
TRK-380 (TAC-301) is an effective and selective β3-adrenergic receptor agonist. TRK-380 improves formalin-induced frequent urination in rats and carbachol-induced bladder contraction in dogs (a decrease of 37.6%). | |||
T40150 |
Trk-IN-6
|
||
Trk-IN-6 shows excellent in vitro potency on a panel of TRK mutants ( IC 50 = 0.2-0.7 nM). | |||
T17169 |
Trk-IN-4
PF-6683324 isomer |
Trk receptor | Tyrosine Kinase/Adaptors |
Trk-IN-4 is an effective pan-Trk inhibitor in cell-based assays (IC50s: 1.9 nM, 2.6 nM, and 1.1 nM for TrkA, TrkB, and TrkC, respectively). | |||
T28129 |
Naltalimide
TRK-130,TRK 130,TRK130 |
||
Naltalimide is a unique µ-opioid receptor partial agonist. Naltalimide also enhances the bladder storage function by modulating the afferent limb of the micturition reflex through µ-opioid receptors in the spinal cord. | |||
T62095 | TRK-IN-19 | ||
TRK-IN-19 (Compound I-10 ) 是一种 TRK 的有效抑制剂,对 TRKA、TRKAG595R 的 IC50 值分别为 1.1 nM、5.3 nM。TRK-IN-19 对癌症疾病表现出潜在的研究价值。 | |||
T61247 |
TRK-IN-16
|
||
TRK-IN-16 (WO2012034091A1, compound X-21) is a highly effective TRK inhibitor, targeting protein kinases that are integral to regulating cell growth, differentiation, and various cellular signal transduction processes. This compound shows great potential for research in TRK-related diseases [1]. | |||
T61872 |
Trk-IN-10
|
||
Trk-IN-10 (Compound 14j) is a highly effective inhibitor of TRK, with an IC50 of 0.86 nM against TrkA and 6.92 nM against TrkA G595R. As an RTK, Trk plays a crucial role as a drug target in solid tumors. Trk-IN-10 (IC50 = 350 nM against ALK) demonstrates superior selectivity in inhibiting Trk, which has potential implications for toxicity reduction [1]. | |||
T62531 |
TRK-IN-12
|
||
TRK-IN-12 (Compound 9e) 是一种大环衍生的有效TRK抑制剂,具有显著的TRKG595R抑制活性 (IC50= 13.1 nM)。在Ba/F3-LMNA-NTRK1细胞系中具有出色的抗增殖效果 (IC50= 0.080 μM),并且在Ba/F3-LMNA-NTRK1-G595R细胞系中展示了超过对照活性分子LOXO-101的抑制能力 (IC50= 0.646 μM)。 | |||
T62561 |
TRK-IN-17
|
||
TRK-IN-17 是一种 TRK 的有效抑制剂。其中原肌球蛋白相关激酶 (Trks) 是受体酪氨酸激酶家族成员,由神经营养因子激活。神经营养因子是一组可溶性生长因子,包括神经生长因子 (NGF)、脑源性神经营养因子 (BDNF) 和神经营养因子-3 (NT-3),以及神经营养因子-4/5 (NT-4/5)。TRK-IN-17 具有潜力进行癌症疾病的研究。 | |||
T63076 |
IHMT-TRK-284
|
||
IHMT-TRK-284 (Compound 34) 是一种有效的、口服具有活力的 type II TRK kinase 抑制剂,能够作用于 TRKA (IC50: 10.5 nM)、TRKB (IC50: 0.7 nM)、TRKC (IC50: 2.6 nM)。IHMT-TRK-284 在激酶组中表现出良好的选择性,体内具有良好的抗肿瘤作用。 | |||
T62806 |
Trk-IN-9
|
||
Trk-IN-9 (Compound 12) 是一种 TRK 的有效抑制剂。Trk-IN-9 对 Km-12 细胞系的增殖具有抑制作用。Trk-IN-9 以浓度依赖性方式诱导 Km-12 细胞凋亡。Trk-IN-9 能够抑制 TRK 的磷酸化,并阻断下游通路。Trk-IN-9 具有潜力进行 NTRK 融合癌症的研究。 | |||
T63346 |
TRK-IN-18
|
||
TRK-IN-18 是 TRK 的有效抑制剂。其中原肌球蛋白相关激酶 (Trks) 是一种受体酪氨酸激酶家族,由神经营养因子激活,神经营养因子是一组可溶性生长因子,包含神经生长因子 (NGF)、脑源性神经营养因子 (BDNF) 和神经营养因子-3 (NT-3),以及神经营养因子-4/5 (NT-4/5)。TRK-IN-18 表现出对癌症疾病的研究潜力。 | |||
T79706 |
TRK-IN-24
|
Trk receptor | Tyrosine Kinase/Adaptors |
TRK-IN-24(compound 10g)是一种针对Trk Receptor的抑制剂,它对TRKA、TRKC、TRKAG595R、TRKAG667C和TRKAF589L的抑制作用的IC50值分别达到5.21、4.51、6.77、1.42和6.13 nM。该化合物在BaF3-CD74-NTRK1G595R和BaF3-CD74-NTRK1G667C异种移植模型中显示出明显的抗肿瘤活性。此外,TRK-IN-24 能有效抑制携带SF、GK、xDFG等单点突变的Ba/F3细胞增殖,其IC50范围为1.43至47.56 nM。 | |||
T62429 | TRK-IN-14 | ||
TRK-IN-14 是一种 TRK 的有效抑制剂。其中蛋白激酶在控制细胞生长和分化中发挥着关键作用,并负责控制多种细胞信号转导过程。TRK-IN-13 对 TRK 相关疾病表现出研究潜力。 | |||
T62428 |
TRK-IN-13
|
||
TRK-IN-13 是一种 TRK 的有效抑制剂。其中蛋白激酶在控制细胞生长和分化中发挥着关键作用,并负责控制多种细胞信号转导过程。TRK-IN-13 对 TRK 相关疾病表现出研究潜力。 | |||
T61443 | Trk-IN-7 | ||
Trk-IN-7 (compound I-6) is a highly potent inhibitor of TRK, exhibiting IC50 values ranging from 0.25-10 nM for TRKA, TRKB, and TRKC, respectively. In addition, Trk-IN-7 demonstrates notable inhibition against EML4-ALK (IC50 <15 nM), as well as ALK G1202R, ALK C1156Y, ALK R1275Q, ALK F1174L, ALK L1197M, and ALK G1269A (IC50 = 5-50 nM) [1]. | |||
T78968 | TRK-IN-23 | Trk receptor | Tyrosine Kinase/Adaptors |
TRK-IN-23 (compound 24b) 是一款口服活性TRK抑制剂,对TRKA、TRKC、TRKAG595R、TRKAF589L和TRKAG667C 表现出高效的抑制作用,其IC50值分别为0.5 nM、9 nM、14 nM、4.4 nM和4.8 nM。此外,TRK-IN-23 能够诱导含有TRKAG595R和TRKAG667C突变的Ba/F3细胞系进行细胞凋亡(apoptosis)。 | |||
T62286 | TRK-IN-21 | ||
TRK-IN-21 (5n) 是一种口服具有活力的 TRK 抑制剂。TRK-IN-21 能够作用于 TRKAWT (IC50: 0.3 nM),TRKAG667C (IC50: 2.3 nM),TRKAF589L (IC50: 0.4 nM)和 TRKAG595 (IC50: 0.5 nM)。TRK-IN-21 能够用于研究癌症。 | |||
T61246 | TRK-IN-15 | ||
TRK-IN-15 (WO2012034091A1, compound X-55) is a highly effective inhibitor of TRK, a protein kinase with crucial involvement in the regulation of cellular growth, differentiation, and signal transduction. Offering significant potential for studying TRK-related diseases, TRK-IN-15 holds promise for advancing research in this field [1]. | |||
T62093 |
Trk-IN-11
|
||
Trk-IN-11 (Compound 14h) 是一种 TRK 的有效抑制剂,对 TrkA、TrkA G595R 的 IC50 值分别为 1.4 nM、1.8 nM。其中原肌球蛋白受体激酶 (Trk) 是一种受体酪氨酸激酶 (RTK),也是实体瘤中关键的药物靶点。Trk-IN-11对癌症疾病表现出研究潜力。 | |||
T61712 | Trk-IN-8 | ||
Trk-IN-8, a powerful TRK inhibitor, demonstrates excellent potency against TRKAa, TRKA(G595R), and TRKC(G623R) with IC50 values of 0.42 nM, 0.89 nM, and 1.5 nM, respectively (WO2021115401A1, compound 3) [1]. | |||
T61551 |
Trk-IN-20
|
||
Trk-IN-20 is a 3-vinylindazole derivative compound that effectively inhibits the functions of Trk kinases. It accomplishes this by suppressing the phosphorylation of TrkA, TrkB, and TrkC, with IC50 values of 1.6 nM, 2.9 nM, and 2.0 nM, respectively [1]. | |||
T73033 | TRK II-IN-1 | Trk receptor | Tyrosine Kinase/Adaptors |
TRKII-IN-1 是一种有效的 II 型TRK抑制剂,对TRKA/B/C及TRKAG667C的IC50分别为3.3、6.4、4.3 和 9.4 nM。此外,TRKII-IN-1 对FLT3、RET和VEGFR2也具有抑制作用,其IC50分别为1.3、9.9 和 71.1 nM。TRKII-IN-1 主要用于TRK驱动的癌症研究。 | |||
T63475 |
Pan-Trk-IN-2
|
||
Pan-Trk-IN-2 是小分子 Trks 抑制剂,表现出良好的抗肿瘤效果。 | |||
T72931 |
TRK/ALK-IN-1
|
||
TRK/ALK-IN-1 是一种有效的 TRK 和 ALK 双重抑制剂。TRK/ALK-IN-1 在酶促测定中与抗增殖活性非常吻合,对 TRKA、ALKIC50值分别为 2.2、9.3 和 38 nM< sup>WT 和 ALKL1196M。TRK/ALK-IN-1具有研究癌症疾病的潜力。 | |||
T64070 | Pan-Trk-IN-3 | ||
Pan-Trk-IN-3 是一种有效的广谱 Trk 及其耐药突变体抑制剂,能够作用于 TrkA (IC50: 2 nM)、TrkB (IC50: 3 nM)、TrkC (IC50: 2 nM)、TrkAG595R (IC50: 21 nM)、TrkAG667C (IC50: 26 nM)、TrkAG667S (IC50: 5 nM)、TrkAF589L (IC50: 7 nM) 和 TrkCG623R (IC50: 6 nM)。Pan-Trk-IN-3 能够诱导细胞凋亡 (apoptosis),具有显著的抗肿瘤效果。 | |||
T72289 | Type II TRK inhibitor 1 | Trk receptor | Tyrosine Kinase/Adaptors |
Type II TRK inhibitor 1 是有效抑制多种TRK融合蛋白及野生型的TRK抑制剂。对携有CD74-TRKAG667C及ETV6-TRKCG696C融合蛋白的Ba/F3细胞表现出抗增殖活性,其IC50值分别为6 nM与1.7 nM。 | |||
T14921 |
CE-245677
|
Tie-2; Trk receptor | Tyrosine Kinase/Adaptors |
CE-245677 是可逆的Tie2和TrkA/B 抑制剂,在细胞体系下的IC50值分别为 4.7 和 1 nM。 | |||
T7568 |
LM22A-4
|
Trk receptor | Tyrosine Kinase/Adaptors |
LM22A-4 是特异性的tyrosine kinase receptor B 激动剂,常用于研究神经系统疾病。 | |||
T5635 |
CH7057288
|
Trk receptor | Tyrosine Kinase/Adaptors |
CH7057288 是选择性TRK 抑制剂。 | |||
T6097 |
GNF-5837
GNF 5837 |
Trk receptor; PDGFR; c-Kit | Angiogenesis; Tyrosine Kinase/Adaptors |
GNF-5837 是一种选择性的,有效的,口服生物利用的泛TRK 抑制剂,在 Ba/F3 细胞中显示出抗增殖作用 (对Tel-TrkC,Tel-TrkB 和Tel-TrkA 的IC50值分别为 7 nM,9 nM 和 11 nM)。 | |||
T7435 |
Selitrectinib
LOXO-195 |
Trk receptor | Tyrosine Kinase/Adaptors |
Selitrectinib (LOXO-195) 是二代原肌凝蛋白相关激酶(TRK)抑制剂,能够作用于 TRKA (IC50:0.6 nM) 和 TRKC (IC50<2.5 nM)。 | |||
T14363 |
AZ-23
AZ 23,AZ23 |
Trk receptor | Tyrosine Kinase/Adaptors |
AZ-23是一种 ATP-竞争性的,口服具有活性的 Trk 激酶 A/B/C 抑制剂,IC50值分别为2 nM (TrkA),8 nM (TrkB),24 nM (FGFR1),52 nM (Flt3),55 nM (Ret),84 nM (MuSk),99 nM (Lck)。 | |||
T2359 |
ANA-12
ANA 12,ANA12 |
Trk receptor | Tyrosine Kinase/Adaptors |
ANA-12 是一种选择性TrkB 拮抗剂,对高亲和力和低亲和力位点的IC50分别为45.6 nM 和41.1 μM。 | |||
T6052 |
GW 441756
|
Apoptosis; Raf; Trk receptor; CDK | Apoptosis; Cell Cycle/Checkpoint; MAPK; Tyrosine Kinase/Adaptors |
GW 441756 是一种高特异性神经生长因子受体酪氨酸激酶 a 抑制剂 ,IC50值为 2 nM,可消除 BmK NSPK 诱导神经突生长。 | |||
T9123 |
DS-1205
|
TAM Receptor | Tyrosine Kinase/Adaptors |
DS-1205b free base 是有效的AXL 激酶选择性抑制剂,IC50为 1.3 nM。它对MER,MET 和TRKA 也有抑制作用,IC50分别为 63、104 和 407 nM。 它可以抑制细胞迁移和肿瘤生长。 | |||
T5995 |
Larotrectinib
LOXO-101,ARRY-470 |
Apoptosis; Trk receptor | Apoptosis; Tyrosine Kinase/Adaptors |
Larotrectinib (LOXO-101)为ATP竞争性、口服选择性抑制剂,针对原肌凝蛋白相关激酶(TRK)家族受体三个亚型(TRKA,B 和C)展现纳摩尔级别的50%抑制浓度。 | |||
T4496 |
LM22B-10
LM22B10 |
ERK; Trk receptor; Akt | Cytoskeletal Signaling; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
LM22B-10 是TrkB/TrkC 神经营养因子受体激活剂,诱导体内外TrkB、TrkC、AKT 和ERK 的活化。 | |||
T8327 |
ONO-7475
|
Trk receptor; TAM Receptor | Tyrosine Kinase/Adaptors |
ONO-7475 是一种选择性的、有效的、具有口服活性的Axl/Mer 抑制剂。它使 AXL 过表达的EGFR 突变型 NSCLC 细胞对 EGFR-TKIs 敏感,抑制耐药细胞的产生和耐药性的维持。它与 Osimertinib 联合使用,具有用于 EGFR 突变非小细胞肺癌的潜力。 | |||
T19649 |
PF-06273340
PF 6273340,PF 06273340,PF6273340,PF-6273340 |
Trk receptor | Tyrosine Kinase/Adaptors |
PF-06273340 是一种口服具有活力的、具有选择性的外周限制性Trk 泛抑制剂。 | |||
T4257 |
Belizatinib
TSR-011 |
Trk receptor; ALK | Angiogenesis; Tyrosine Kinase/Adaptors |
Belizatinib (TSR-011) 是可口服的ALK 和 TRKA、TRKB、TRKC 双重抑制剂,对野生型重组 ALK 的IC50值为0.7 nM。 | |||
T4071 |
Repotrectinib
TPX-0005,TPX 0005,TPX0005 |
Trk receptor; ROS; Src; ALK; ROS Kinase | Angiogenesis; Immunology/Inflammation; Tyrosine Kinase/Adaptors |
Repotrectinib (TPX-0005) 是ROS1(IC50=0.07 nM) 和TRK(对 TRKA/B/C 的IC50=0.83/0.05/0.1 nM) 抑制剂,能够抑制 WTALK(IC50=1.01 nM)。它具有抗癌作用。 | |||
T40019 |
Thalidomide-5-NH2-CH2-COOH
|
Others | Others |
Thalidomide-5-NH2-CH2-COOH (compound 114) 是原肌球蛋白受体激酶的选择性抑制剂。它是 E3 连接酶的配体,具有研究一种或多种疾病的潜力。 | |||
T2054 |
Altiratinib
DCC-2701 |
VEGFR; Tie-2; FLT; Trk receptor; c-Met/HGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Altiratinib (DCC-2701) 是一种多靶点激酶抑制剂,能够抑制 MET (IC50:2.7 nM),TIE2 (IC50:8 nM),VEGFR2 (IC50:9.2 nM),FLT3 (IC50:9.3 nM),Trk1 (IC50:0.85 nM),Trk2 (IC50:4.6 nM) 和 Trk3 (IC50:0.83 nM)。 | |||
T6712 |
Tyrphostin AG 879
AG 879 |
Apoptosis; EGFR; Trk receptor; HER; PDGFR | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin AG 879 (AG 879) 是一种抑制TrKA 磷酸化的酪氨酸激酶抑制剂,IC50为 10 μM。它还是一种选择性ErbB2酪氨酸激酶抑制剂,IC50为 1 μM,具有抗癌活性。 | |||
T3678 |
Entrectinib
RXDX-101,恩曲替尼,NMS-E628 |
Trk receptor; ROS; ALK; Autophagy; ROS Kinase | Angiogenesis; Autophagy; Immunology/Inflammation; Tyrosine Kinase/Adaptors |
Entrectinib (RXDX-101) 是一种可口服的 Trk、ROS1和 ALK 抑制剂,具有抗肿瘤和中枢神经活性,抑制 TrkA、TrkB、TrkC、ROS1 和 ALK 的 IC50值分别为 1、3、5、12 和 7 nM。 | |||
T0678 |
Amitriptyline hydrochloride
Amitriptyline HCl,Tryptizol,盐酸阿米替林,Domical,Annoyltin |
Trk receptor; Sigma receptor; 5-HT Receptor; Serotonin Transporter; Sodium Channel; Adrenergic Receptor; AChR; Norepinephrine; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Membrane transporter/Ion channel; Neuroscience; Tyrosine Kinase/Adaptors |
Amitriptyline hydrochloride (Annoyltin) 是血清素再摄取转运体和去甲肾上腺素再摄取转运体抑制剂,还与多巴胺再摄取转运体结合,其Ki 为 2.58 μM。它也抑制肾上腺素能受体、毒蕈碱受体、组胺受体、5-羟色胺受体。它是TrkA 和TrkA 受体的激动剂,具有强神经营养活性和有抗抑郁作用。 | |||
T6880 |
Larotrectinib sulfate
LOXO-101 sulfate,Larotrectinib (LOXO-101) sulfate,Larotrectinib,LOXO-101 (sulfate),ARRY-470,ARRY-470 (sulfate) |
Apoptosis; Trk receptor | Apoptosis; Tyrosine Kinase/Adaptors |
Larotrectinib sulfate (LOXO-101 sulfate) 是一种 ATP 竞争性的,口服选择性抑制剂,对原肌凝蛋白相关激酶家族受体的三个亚型具有纳摩尔级别的 50% 抑制浓度。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2816 |
7,8-Dihydroxyflavone
二羟基黄酮水合物,7,8-DHF |
Apoptosis; Trk receptor | Apoptosis; Tyrosine Kinase/Adaptors |
7,8-Dihydroxyflavone (7,8-DHF) 是一种选择性有效的TrkB 激动剂,其模拟脑源性神经营养因子的生理作用。它有潜力研究各种神经疾病。 | |||
T1354 |
N-Acetyl-5-hydroxytryptamine
Normelatonin,N-乙酰-5-羟色胺,O-Demethylmelatonin,N-Acetylserotonin |
Trk receptor; Endogenous Metabolite | Metabolism; Tyrosine Kinase/Adaptors |
N-Acetyl-5-hydroxytryptamine (O-Demethylmelatonin) 是褪黑激素的直接前体,能够有效激活TrkB 受体。 | |||
T1716 |
Echinacoside
|
Reactive Oxygen Species; Wnt/beta-catenin | Cytoskeletal Signaling; Immunology/Inflammation; Metabolism; NF-κB; Stem Cells |
Echinacoside 是一种从Cistanche salsa 中分离的苯乙醇类化合物,抑制Wnt/β-catenin 信号通路。它能够激活 Trk 受体及其下游信号通路而起到神经保护作用,还具有显著的抗骨质疏松作用。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01084 |
TrkA Protein, Human, Recombinant (His)
TRK1,TRK,TRKA,neurotrophic tyrosi... |
Human | HEK293 Cells |
TrkA Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 39.5 kDa and the accession number is P04629-1. | |||
TMPY-00751 |
TrkB Protein, Human, Recombinant (His)
trk-B,GP145-TrkB/GP95-TrkB,neurot... |
Human | HEK293 Cells |
TrkB Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 45.7 kDa and the accession number is Q16620-2. | |||
TMPY-02231 |
TrkB Protein, Mouse, Recombinant (His)
trk-B,neurotrophic tyrosine kinase, receptor, type ... |
Mouse | HEK293 Cells |
TrkB Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 46 kDa and the accession number is P15209-2. | |||
TMPY-01760 |
TrkA Protein, Human, Recombinant (aa 194-413, His)
neurotrophic tyrosine kinase, receptor, type 1,MTC,Trk |
Human | HEK293 Cells |
TrkA Protein, Human, Recombinant (aa 194-413, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 26 kDa and the accession number is P04629-1. | |||
TMPK-00774 |
TrkA Protein, Human, Recombinant (aa 33-417, His)
TrkAI,TrkA I,Trk-A,TRKA,... |
Human | HEK293 Cells |
TrkA, a tyrosine kinase receptor, is an essential component of the nerve growth factor (NGF) response pathway. The binding of NGF to the receptor induces receptor autophosphorylation and activation of intracellular signaling pathways, resulting in diverse biological effects. | |||
TMPY-01759 |
TrkA Protein, Human, Recombinant (aa 285-413, His)
neurotrophic tyrosine kinase, receptor, type 1,p140-Trk<... |
Human | E. coli |
TrkA Protein, Human, Recombinant (aa 285-413, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 15.1 kDa and the accession number is P04629-1. | |||
TMPY-01083 |
TrkA Protein, Human, Recombinant (His & hFc)
TRKA,p140-TrkA,MTC,Trk-A,TRK<... |
Human | HEK293 Cells |
TrkA Protein, Human, Recombinant (His & hFc) is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 66 kDa and the accession number is P04629-1. | |||
TMPY-03536 |
TrkA Protein, Mouse, Recombinant (His)
neurotrophic tyrosine kinase, receptor, type 1,trk,... |
Mouse | HEK293 Cells |
TrkA Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.7 kDa and the accession number is Q3UFB7. | |||
TMPY-03470 |
TrkA Protein, Mouse, Recombinant (hFc)
TrkA,C80751,neurotrophic tyrosine kinase, receptor,... |
Mouse | HEK293 Cells |
TrkA Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 69.2 kDa and the accession number is Q3UFB7. | |||
TMPY-05509 |
TrkB Protein, Human, Recombinant (hFc)
GP145-TrkB/GP95-TrkB,trk-B,neurot... |
Human | HEK293 Cells |
TrkB Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 70.9 kDa and the accession number is Q16620-2. | |||
TMPY-02484 |
SLITRK4 Protein, Human, Recombinant (His)
DKFZp547M2010,SLIT and NTRK like family member 4 |
Human | HEK293 Cells |
SLIT and NTRK-like family proteins 4 is a member of the SLIT and NTRK-like family. This protein is characterized as an integral membrane protein that has two leucine-rich repeat (LRR) domains and a carboxy-terminal domain that is partially similar to SLIT protein and TRK Neurotrophin There are six members in this family: SLITRK1, SLITRK2, SLITRK3, SLITRK4, SLITRK5, and SLITRK6. Their expression was detected mainly in the brain, but the expression profile of each SLITRK was unique. Each of these ... | |||
TMPY-00923 |
SLITRK1 Protein, Human, Recombinant (His)
TTM,FLJ54428,LRRC12,RP11-395N17.1,KIAA0918,SLITRK1,... |
Human | HEK293 Cells |
SLITRK1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 105-115 kDa and the accession number is Q96PX8. | |||
TMPY-06967 |
TrkA Protein, Cynomolgus, Recombinant (His)
neurotrophic tyrosine kinase, receptor, type 1 |
Cynomolgus | HEK293 Cells |
TrkA Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.95 kDa and the accession number is XP_005541454.3. | |||
TMPY-03063 |
SLITRK6 Protein, Human, Recombinant (His)
SLIT and NTRK like family member 6,SLITRK6... |
Human | HEK293 Cells |
SLITRK6 belongs to the SLITRK family. Members of this family share two conserved leucine-rich repeat domains in the extracellular domain. SLITRK6 contains 11 LRR (leucine-rich) repeats, 2 LRRCT domains and 2 LRRNT domains. Expression of SlITRK proteins is highly restricted to neural and brain tumor tissues, but varies within the protein family. SLITRK6 is highly expressed in putamen with no expression in cerebral cortex. It also can be detected in adult and fetal lung and fetal liver. It can sup... | |||
TMPY-03635 |
TrkB Protein, Canine, Recombinant (His)
neurotrophic tyrosine kinase, receptor, type 2 |
Canine | HEK293 Cells |
TrkB Protein, Canine, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.7 kDa and the accession number is XP_541264.2. | |||
TMPY-04285 |
TrkA Protein, Rat, Recombinant (His)
neurotrophic tyrosine kinase, receptor, type 1 |
Rat | HEK293 Cells |
TrkA Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.7 kDa and the accession number is A6J617. | |||
TMPY-00922 |
SLITRK1 Protein, Human, Recombinant (His & hFc)
KIAA0918,KIAA1910,SLIT and NTRK like family member ... |
Human | HEK293 Cells |
SLITRK1 Protein, Human, Recombinant (His & hFc) is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 95 kDa and the accession number is Q96PX8. | |||
TMPY-04663 |
TrkA Protein, Rabbit, Recombinant (His)
neurotrophic tyrosine kinase, receptor, type 1 |
Rabbit | HEK293 Cells |
TrkA Protein, Rabbit, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 43.4 kDa and the accession number is XP_008262512.1. | |||
TMPY-03162 |
TrkB Protein, Rat, Recombinant (His)
neurotrophic tyrosine kinase, receptor, type 2 |
Rat | HEK293 Cells |
TrkB Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 47.1 kDa and the accession number is Q63604. | |||
TMPY-03560 |
TrkA Protein, Rat, Recombinant (hFc)
neurotrophic tyrosine kinase, receptor, type 1 |
Rat | HEK293 Cells |
TrkA Protein, Rat, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 69.2 kDa and the accession number is P35739. | |||
TMPY-03712 |
TrkA Protein, Canine, Recombinant (His)
neurotrophic tyrosine kinase, receptor, type 1 |
Canine | HEK293 Cells |
TrkA Protein, Canine, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 16.2 kDa and the accession number is XP_851619.3. | |||
TMPY-00945 |
TrkC Protein, Human, Recombinant (His)
TRKC,gp145(trkC),neurotrophic tyrosine kin... |
Human | HEK293 Cells |
TrkC Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 46.1 kDa and the accession number is Q16288-2. | |||
TMPY-00228 |
TrkB Protein, Canine, Recombinant (hFc)
neurotrophic tyrosine kinase, receptor, type 2 |
Canine | HEK293 Cells |
TrkB Protein, Canine, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 71.2 kDa and the accession number is XP_541264.2. | |||
TMPY-00944 |
TrkC Protein, Human, Recombinant (His & hFc)
TRKC,neurotrophic tyrosine kinase, receptor, type 3... |
Human | HEK293 Cells |
TrkC Protein, Human, Recombinant (His & hFc) is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 72.5 kDa and the accession number is Q16288-2. | |||
TMPY-01223 |
TrkC Protein, Mouse, Recombinant (His)
TrkC,Ntrk3_tv3,AW125844,neurotrophic tyros... |
Mouse | HEK293 Cells |
TrkC Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 46.1 kDa and the accession number is Q6VNS1-1. | |||
TMPY-03711 |
TrkA Protein, Canine, Recombinant (hFc)
neurotrophic tyrosine kinase, receptor, type 1 |
Canine | HEK293 Cells |
TrkA Protein, Canine, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 42.3 kDa and the accession number is XP_851619.3. | |||
TMPY-02917 |
TrkB Protein, Rat, Recombinant (hFc)
neurotrophic tyrosine kinase, receptor, type 2 |
Rat | HEK293 Cells |
TrkB Protein, Rat, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 71.5 kDa and the accession number is Q63604-1. |